Expression of Serum miR-24 and miR-106a Levels in Patients with Acute Myeloid Leukemia and Its Clinical Diagnostic Value
10.3969/j.issn.1671-7414.2024.05.001
- VernacularTitle:急性髓系白血病患者血清miR-24,miR-106a水平表达及其临床诊断价值
- Author:
Ting LUO
1
;
Yunxiao DUAN
;
Hao ZHONG
;
Kai SHEN
Author Information
1. 四川大学华西医院血液内科\四川大学华西护理学院,成都 610041
- Keywords:
acute myeloid leukemia;
miR-24;
miR-106a;
clinicopathologic features
- From:
Journal of Modern Laboratory Medicine
2024;39(5):1-5,68
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of serum micro RNA(miR)-24,miR-106a levels and their clinical diagnostic value in patients with acute myeloid leukemia(AMI).Methods A sum of 98 patients with AML admitted to West China Hospital of Sichuan University from June 2018 to June 2020 were selected as the study group.These patients were separated into complete remission group,partial remission group,and non remission group based on their efficacy.Meanwhile,another 98 patients undergoing physical examination were regarded as the control group.Serum miR-24 and miR-106a were detected using qRT-PCR.Kaplan-Meier survival curve was applied to analyze the relationship between the levels of miR-24,miR-106a,and the prognosis of AML patients.Receiver operating characteristic(ROC)curve was applied to analyze the diagnostic value of serum miR-24 and miR-106a in patients with AML.Results Compared with the control group,serum miR-24 expression level(0.62±0.16 vs 1.01±0.21)was lower,but miR-106a expression level(1.64±0.38 vs 1.02±0.24)was higher in the study group,with significant differences(t=14.624,13.656,all P＜0.05).The serum miR-24 level was sequentially decreased,but the serum miR-106a level was sequentially increased in the complete remission,partial remission and non-remission groups,with significant differences(F=65.207,24.280,all P＜0.05).The expression levels of miR-24 and miR-106a were related to splenomegaly and WBC(x2=5.029,6.153;9.216,8.151,all P＜0.05).The survival rate of the miR-24 high expression group was higher than that of the low expression group(59.57％vs 39.22％,x2=9.851,P＜0.05),but the survival rate of the miR-106a high expression group was lower than that of the low expression group(38.00％vs 60.42％,x2=21.728,P＜0.05).According to the ROC curve,the areas under the curve(AUC)for diagnosing AML patients with serum miR-24 and miR-106a were 0.894 and 0.880,respectively.The AUC of patients with acute myeloid leukemia diagnosed by the combination of the two was 0.929,which was superior to their respective individual diagnoses(Z=2.624,2.735,all P＜0.05).Conclusion The serum miR-24 level is reduced,but miR-106a level is increased in patients with acute myeloid leukemia.The combination of the two can improve its diagnostic value.
